| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 4.070 | 56.906 | 59.644 | 78.294 | 85.458 |
| Total Income - EUR | - | - | - | - | - | 4.070 | 56.907 | 59.645 | 78.295 | 85.460 |
| Total Expenses - EUR | - | - | - | - | - | 2.491 | 27.429 | 32.221 | 36.511 | 49.729 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 1.578 | 29.478 | 27.423 | 41.784 | 35.731 |
| Net Profit/Loss - EUR | - | - | - | - | - | 1.578 | 29.047 | 26.827 | 41.001 | 33.167 |
| Employees | - | - | - | - | - | 1 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Zanfamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 19.370 | 17.068 | 15.244 | 13.367 | 47.466 |
| Current Assets | - | - | - | - | - | 4.296 | 14.464 | 22.733 | 30.882 | 24.462 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 3.934 | 5.493 | 19.315 | 13.636 | 1.874 |
| Cash | - | - | - | - | - | 361 | 8.971 | 3.418 | 17.246 | 22.589 |
| Shareholders Funds | - | - | - | - | - | 1.620 | 29.087 | 26.867 | 41.041 | 33.207 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 22.046 | 2.445 | 11.109 | 3.208 | 38.721 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Zanfamed S.r.l.